These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21181214)

  • 21. Contribution of osteocalcin-mimetic peptide enhances osteogenic activity and extracellular matrix mineralization of human osteoblast-like cells.
    Hosseini S; Naderi-Manesh H; Vali H; Baghaban Eslaminejad M; Azam Sayahpour F; Sheibani S; Faghihi S
    Colloids Surf B Biointerfaces; 2019 Jan; 173():662-671. PubMed ID: 30368214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interactions with growth hormone.
    Langdahl BL; Kassem M; Møller MK; Eriksen EF
    Eur J Clin Invest; 1998 Mar; 28(3):176-83. PubMed ID: 9568461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement by sodium orthovanadate of the formation and mineralization of bone nodules by chick osteoblasts in vitro.
    Johnson RB; Henderson JS
    Arch Oral Biol; 1997 Apr; 42(4):271-6. PubMed ID: 9222445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation.
    Matsuguchi T; Chiba N; Bandow K; Kakimoto K; Masuda A; Ohnishi T
    J Bone Miner Res; 2009 Mar; 24(3):398-410. PubMed ID: 19016586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The stimulatory effect of insulin-like growth factor-1 on the proliferation, differentiation, and mineralisation of osteoblastic cells from Holstein cattle.
    Li SH; Guo DZ; Li B; Yin HB; Li JK; Xiang JM; Deng GZ
    Vet J; 2009 Mar; 179(3):430-6. PubMed ID: 18406640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo and in vitro effects of insulin-like growth factor-I (IGF-I) on femoral mRNA expression in old rats.
    Tanaka H; Quarto R; Williams S; Barnes J; Liang CT
    Bone; 1994; 15(6):647-53. PubMed ID: 7873293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombospondin co-localises with TGF beta and IGF-I in the extracellular matrix of human osteoblast-like cells and is modulated by 17 beta estradiol.
    Slater M; Patava J; Mason RS
    Experientia; 1995 Mar; 51(3):235-44. PubMed ID: 7698287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
    Lee CH; Huang YL; Liao JF; Chiou WF
    Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sanguis Draconis resin stimulates osteoblast alkaline phosphatase activity and mineralization in MC3T3-E1 cells.
    Wang W; Olson D; Cheng B; Guo X; Wang K
    J Ethnopharmacol; 2012 Jun; 142(1):168-74. PubMed ID: 22543168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-carnitine and isovaleryl L-carnitine fumarate positively affect human osteoblast proliferation and differentiation in vitro.
    Colucci S; Mori G; Vaira S; Brunetti G; Greco G; Mancini L; Simone GM; Sardelli F; Koverech A; Zallone A; Grano M
    Calcif Tissue Int; 2005 Jun; 76(6):458-65. PubMed ID: 15906015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation.
    Song L; Zhao J; Zhang X; Li H; Zhou Y
    Eur J Pharmacol; 2013 Aug; 714(1-3):15-22. PubMed ID: 23764463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteogenic activity of vanadyl(IV)-ascorbate complex: evaluation of its mechanism of action.
    Cortizo AM; Molinuevo MS; Barrio DA; Bruzzone L
    Int J Biochem Cell Biol; 2006; 38(7):1171-80. PubMed ID: 16455285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that IGF-binding protein-5 functions as a growth factor.
    Miyakoshi N; Richman C; Kasukawa Y; Linkhart TA; Baylink DJ; Mohan S
    J Clin Invest; 2001 Jan; 107(1):73-81. PubMed ID: 11134182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization.
    Brandao-Burch A; Utting JC; Orriss IR; Arnett TR
    Calcif Tissue Int; 2005 Sep; 77(3):167-74. PubMed ID: 16075362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol suppresses insulin-like growth factor I-induced osteoblast migration: attenuation of the p44/p42 MAP kinase pathway.
    Hioki T; Kawabata T; Sakai G; Fujita K; Kuroyanagi G; Matsushima-Nishiwaki R; Kim W; Otsuka T; Iida H; Tokuda H; Kozawa O
    Biosci Biotechnol Biochem; 2020 Dec; 84(12):2428-2439. PubMed ID: 32862787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity.
    Addison WN; Azari F; Sørensen ES; Kaartinen MT; McKee MD
    J Biol Chem; 2007 May; 282(21):15872-83. PubMed ID: 17383965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts.
    Kanno T; Takahashi T; Tsujisawa T; Ariyoshi W; Nishihara T
    J Cell Biochem; 2007 Aug; 101(5):1266-77. PubMed ID: 17265428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts.
    Conover CA; Khosla S
    Growth Horm IGF Res; 2003 Dec; 13(6):328-35. PubMed ID: 14624766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D control of osteoblast function and bone extracellular matrix mineralization.
    van Leeuwen JP; van Driel M; van den Bemd GJ; Pols HA
    Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):199-226. PubMed ID: 11693961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.
    Posritong S; Hong JM; Eleniste PP; McIntyre PW; Wu JL; Himes ER; Patel V; Kacena MA; Bruzzaniti A
    Mol Cell Endocrinol; 2018 Oct; 474():35-47. PubMed ID: 29428397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.